CAS: 31112-62-6; 3-Acetamido-2,4,6-Triiodo-5-(N-Methylacetamido)-N-((2R,3R,4S,5R)-3,4,5,6-Tetrahydroxy-1-Oxohexan-2-yl)Benzamide

该化合物是一种复杂的有机化合物,其结构特征包括脱氧糖和三基双苯基化合物.该化合物是D-甘糖的衍生物,是一种简单的糖和生物系统中的一种基本碳水化合物.乙基氨基和乙基甲基氨基化合物的存在表明,该化合物已经经过改造,以强化其化学特性,有可能影响其溶性,再活性和生物活动.三碘乙基苯基混合物表明,该化合物在成像或治疗环境中,特别是在由于碘的放射特性而进行医学诊断时,可能具有应用性.化学文摘第31112-66号化学文摘第31112-62-6号化学数据库中对这种物质进行了独特的识别,便利其研究和应用于研究和工业.

结构式图片

上下游产品

N-Methyl-3,5-diacetamido-2,4,6-triiodobenzoyl chloride D-glucosamine hydr°Chloride pyrographite

合成工艺路线路线简述

    N-Methyl-3,5-Diacetamido-2,4,6-Triiodobenzoyl Chloride,D-Glucosamine Hydrochloride,甲烷置于potassium Carbonate体系中,用 四氢呋喃,水,N,N-二甲基甲酰胺 用作溶剂,化学反应生成甲泛葡胺
    参考文献:Amido Derivatives Of 2,4,6-Triiodobenzoic Acids Containing At Least One
    标题:Amido Derivatives Of 2,4,6-Triiodobenzoic Acids Containing At Least One
    摘要:这项发明涉及新型x射线造影剂,特别用于脑脊液腔,包括携带至少一个n-键合的二次或三次酰胺基团并且分子中至少有两个羟基和至少一个碘原子的非离子烷醇.特别有用的化合物包括至少有两个羟基的n-羟基烷基碘烷磺酰胺,携带氨基甲酰,酰胺基或酰氨基甲基取代基并且分子中至少有两个羟基和至少一个n-羟基的三碘苯和四碘苯.特别优选的化合物包括2,4,6-三碘苯酰胺,它们可能在3-和/或5-位置上被各种基团取代.这些化合物都表现出明显低的毒性,其中一些化合物具有非常高的水溶性水平.

    海关参考信息

    专利信息


    专利号:US-12383499-B2
    优先权日:2018-01-01
    标题:Scale up synthesis of silicasome nanocarriers
    发明人:NEL ANDRE E; MENG HUAN; LIU XIANGSHENG
    权利人:UNIV CALIFORNIA
    摘要:In order to facilitate the approval and commercialization of silicasome drug delivery systems (e.g. irinotecan silicasomes) it is necessary to scale up synthesis of the drug-loaded silicasomes. In this regard, it was discovered that the synthesis protocols used for laboratory synthesis of drug-loaded silicasomes (e.g., 500 mg/batch) do not scale to large scale silicasome production, because the resulting products were too heterogeneous for use as pharmaceuticals. Accordingly, new methods are provided herein that effectively afford the large-scale production of mesoporous silica nanoparticles (MSNPs) and lipid bilayer coated MSNPs (silicasomes).

    专利号:US-2022233673-A1
    优先权日:2019-06-04
    标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
    发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
    权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
    摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

    专利号:US-11718864-B2
    优先权日:2015-09-23
    标 题 :Cells and method of cell culture
    发明人:HILLER GREGORY WALTER; MITCHELL JEFFREY JOSEPH; MULUKUTLA BHANU CHANDRA; PEGMAN PAMELA MARY
    权利人:PFIZER
    摘要:The invention relates to a method of cell culture where the cells are modified to reduce the level of synthesis of growth and/or productivity inhibitors by the cell. The invention also relates to a method of cell culture for improving cell growth and productivity, in particular in fed-batch culture of mammalian cells at high cell density. The invention further relates to a method of producing cells with improved cell growth and/or productivity in cell culture and to cells obtained or obtainable by such methods.

    专利号:US-9238615-B2
    优先权日:2009-04-21
    标 题 :Process for the iodination of aromatic compounds
    发明人:CITTERIO ATTILIO; LATTUADA LUCIANO; LEONARDI GABRIELLA; UGGERI FULVIO; VIGNALE EVELIN; VISIGALLI MASSIMO; FERRIGATO AURELIA; MELI GABRIELE; FRETTA ROBERTA; MAZZON ROBERTA
    权利人:CITTERIO ATTILIO; LATTUADA LUCIANO; LEONARDI GABRIELLA; UGGERI FULVIO; VIGNALE EVELIN; VISIGALLI MASSIMO; FERRIGATO AURELIA; MELI GABRIELE; FRETTA ROBERTA; MAZZON ROBERTA; BRACCO IMAGING SPA
    摘要:The present invention relates to a process for the preparation of iodinated anilines; in particular, it relates to a process including the direct iodination, with suitably activated iodine, of 3,5-disubstituted anilines to the corresponding 3,5-disubstituted-2,4,6-triiodoanilines, which are useful intermediates for the synthesis of x-ray contrast media, and to the preparation of the contrast media themselves.

    专利号:US-9193659-B2
    优先权日:2008-02-20
    标 题 :Process for the iodination of aromatic compounds
    发明人:GIOVENZANA GIOVANNI BATTISTA; CAVALLOTTI CAMILLA; LATTUADA LUCIANO; UGGERI FULVIO
    权利人:GIOVENZANA GIOVANNI BATTISTA; CAVALLOTTI CAMILLA; LATTUADA LUCIANO; UGGERI FULVIO; BRACCO IMAGING SPA
    摘要:The present invention relates to a process for the preparation of iodinated phenols, —in particular, it relates to a process including the electrochemical iodination of 3,5-disubstituted phenols of formula (1) to the corresponding 3,5-disubstituted-2, 4,6-triiodophenols of formula (2), which are useful intermediates for the synthesis of x-ray contrast media, and to the preparation of the contrast media themselves. Furthermore, the present invention includes the electrochemical iodination of 3, 5- disubstituted anilines of formula (6) to the corresponding 3,5-disubstituted-2,4,6-triiodoanilins of formula (7).

    专利号:US-2011104052-A1
    优先权日:2007-12-03
    标 题 :Methods of synthesis and use of chemospheres
    发明人:BARNETT BRADLEY POWERS; GESCHWIND JEFFREY
    权利人:UNIV JOHNS HOPKINS
    摘要:The present invention provides, in general, compositions comprising a hydrogel and an agent, for example a therapeutic agent or an imaging agent, for locoregional delivery. In certain preferred embodiments of the invention, the hydrogel compositions are detectable by Magnetic Responance and CT Scan and are used for locoregional delivery of therapeutic agents, for example chemotherapeutic agents. The invention also features polymer matrix compositions comprising nanoparticles that can be loaded after polymerization with bioactive agents, for example a diagnostic agent or therapeutic agent.
    上海东满进出口有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.domen.com.cn
    企业联系电话:021-61066956/57/58,61043548👤
    📞上海东满进出口有限公司 ⚠️参考联系方式
    联系人:董连锁
    电话:021-61066956/57/58,61043548

    传真:021-61043546
    邮箱:sales@domen.com.cn
    通信地址: 上海市浦东新区新金桥路1088号中惠广场A座1907室
    邮编: 201206
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区新金桥路1088号中惠广场A座1907室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Grobovschek M. [Lumbosacral functional myelography including the dorsolumbar transitional region (medullary cone). Clinical comparative studies--2000 myelographies with metrizamide]. Radiologe. 1984 Aug;24(8):389-98. Review. German. Review. Review. Review. Review. Review. Review. Review. Review.

    合成参考文献


    摘要:Drugs in Japan, 6(842), 1982
    摘要:Investigative Radiology., 15(S248), 1980 []
    摘要:Yakkyoku. Pharmacy., 32(865), 1981
    摘要:United States Patent Document., #4001323
    摘要:Journal of the American College of Toxicology., 9(563), 1990
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知